About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Dallas | 13,744 Studies Near You

Clinical TrialsDallas

Clinical Trials in Dallas

Discover 13,744 clinical trials near Dallas, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6301-6320 of 13,744 trials

CompletedReversing Corticosteroid Induced Memory ImpairmentMedically stable outpatients receiving chronic oral corticosteroid therapy were enrolled in a 48-week randomized, double-blind, placebo-controlled, parallel-group, trial of…NCT01142310·Dallas, Texas CompletedEfficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut AllergyThe objectives of this dose-finding study for the treatment of peanut allergy are: * To determine the efficacy of 3 doses of Viaskin Peanut (50 mcg ,100 mcg and 250 mcg peanut…NCT01675882·San Diego, California and 23 others

Find Trials by Condition in Dallas

Breast Cancerin Dallas Lung Cancerin Dallas Prostate Cancerin Dallas Colorectal Cancerin Dallas Melanomain Dallas Leukemiain Dallas Lymphomain Dallas Pancreatic Cancerin Dallas Ovarian Cancerin Dallas Brain Cancerin Dallas Diabetesin Dallas

Data from ClinicalTrials.govTerms

RecruitingEfficacy of Tezepelumab in Peanut Oral ImmunotherapyThe proposed study is a proof-of-concept Phase 2, double-blind, randomized placebo-controlled clinical trial evaluating the safety and efficacy of tezepelumab and peanut Oral…NCT07015996·Little Rock, Arkansas and 9 others

CompletedSAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy SubjectsA Phase 1 Open-Label, Single Arm Dose Escalation Study to Evaluate the Safety and Tolerability of Intravitreally Administered VP-001 in Participants with Confirmed PRPF31…NCT05902962·Jacksonville, Florida and 5 others

CompletedCombination Study of SV-BR-1-GM With RetifanlimabThis is an open-label, phase I/II double arm study of the SV-BR-1-GM regimen in combination with retifanlimab in patients with metastatic or locally recurrent breast cancer who…NCT03328026·Newport Beach, California and 13 others

CompletedPediatric Radiation Oncology With Movie Induced Sedation Effect (PROMISE)PROMISE (Pediatric Radiation Oncology with Movie Induced Sedation Effect) is an interactive incentive-based movie system that integrates with a video surveillance gating module…NCT05148078·Dallas, Texas

RecruitingCA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)This is a multi-center, open-label study to evaluate the safety, pharmacokinetics (PK), and anti-cancer activity of oral administration of emavusertib alone or in combination with…NCT03328078·Phoenix, Arizona and 44 others

CompletedEfficacy and Safety of Tralokinumab Administered by an Autoinjector in Adults and Adolescents With Moderate to Severe Atopic Dermatitis (INJECZTRA)The purpose of this trial is to evaluate the efficacy and safety of tralokinumab administered as subcutaneous (SC) injection by an autoinjector in adults and adolescents (age 12…NCT05194540·Birmingham, Alabama and 28 others

TerminatedTesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBCCONTESSA is a multinational, multicenter, randomized, Phase 3 study of tesetaxel in patients with HER2 negative, HR positive LA/MBC previously treated with a taxane in the…NCT03326674·Chandler, Arizona and 206 others

CompletedExploratory Study, Evaluating the Treatment Effect of Surgery Plus GLIADEL® Wafer in Patients With Metastatic Brain CancerThe purpose of this study is to determine the effect of the surgical intervention and insertion of GLIADEL wafers on the neurocognitive functioning in patients with metastatic…NCT00525590·Tucson, Arizona and 16 others

CompletedImpact of Liraglutide 3.0 on Body Fat DistributionThis study is a clinical study to investigate the efficacy of liraglutide compared to placebo in reducing visceral adiposity measured by MRI in overweight or obese subjects at…NCT03038620·Dallas, Texas

CompletedEfficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry DiseaseThis study aimed to determine the efficacy and safety of lucerastat oral monotherapy in adult subjects with Fabry disease.NCT03425539·Birmingham, Alabama and 48 others

RecruitingA Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Researchers are looking for a better way to treat people who have advanced non-small cell lung cancer (NSCLC) with specific genetic changes called human epidermal growth factor…NCT06452277·Newport Beach, California and 278 others

CompletedA Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or LeiomyosarcomaThe purpose of this study is to evaluate whether overall survival for the trabectedin group is superior to the dacarbazine group for patients with advanced L-sarcoma (liposarcoma…NCT01343277·Phoenix, Arizona and 87 others

TerminatedStudy of LAU-7b for the Treatment of Coronavirus Disease 2019 (COVID-19) Disease in AdultsA randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patients at a higher risk of complications.NCT04417257·Chandler, Arizona and 28 others

RecruitingVITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid TumorsThis trial is a multi-center, non-randomized, open-label Phase I/II study evaluating the feasibility and efficacy of vincristine, irinotecan, temozolomide, and atezolizumab in…NCT04796012·Chicago, Illinois and 6 others

CompletedA Prospective Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck CancerVarian Medical Systems has recently deployed a completely novel radiation treatment system called EthosTM, a first-of-its-kind system that allows for daily adapative radiotherapy…NCT04883281·Dallas, Texas

Active not recruitingTrial of Ibrutinib Plus Trastuzumab in HER2-amplified Metastatic Breast CancerThis is a Phase I/II, open-label dose-escalation study designed to evaluate the maximum tolerated dose (MTD) and dose-limiting side effects of ibrutinib (560 or 840 or 420 mg…NCT03379428·Dallas, Texas

CompletedSeneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesRATIONALE: Seneca Valley virus-001 may be able to kill certain kinds of tumor cells without damaging normal cells.NCT01048892·Birmingham, Alabama and 17 others

CompletedOpen-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal MenThe purpose of this one year extension (follow-up) study is to gather additional safety data in hypogonadal men treated with oral TU or AndroGel who have completed the 12-month…NCT01699178·Birmingham, Alabama and 29 others

PreviousPage 316 of 688Next

Heart Diseasein Dallas